Saturday, September 12, 2009
Mesalamine
Welcome To mesalamine
Last December P&G's then-CEO Alan Lafley moaned that the increasing complexity and expense of gaining a new drug approval had made the pharmaceuticals business far less profitable. Today, P&G announced a deal to sell its entire prescription drug division in a $3.1 billion deal with specialty drugmak ... Oral Solution), VISICOL(R) (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, APRISO(TM) (mesalamine) extended-release capsules 0.375 g., PEPCID(R) (famotidine) for Oral Suspension, Oral Suspension Procter & Gamble has sold its pharmaceutical unit to Warner Chilcott, a specialty pharmaceutical company based in Ireland,for $3.1 billion. The business had revenues of approximately $2.3 billion, and net income of approximately $540 million for the year ended June 30, 2009. "This move enables us to ... These medicines help to relieve symptoms and inflammation in the intestines and help IBD go into remission(a period without symptoms). They also may help prevent the disease from becoming active again. However, they are more effective as long term treatment for Ulcerative Colitis than with long term ...
Blog from:
Site about mesalamine.
BUY ONLINE!
CLICK HERE!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment